However, the CD8+ T cell infiltrate is heterogenous, and we and others have recently shown that only a fraction of the tumor-infiltrating lymphocyte (TIL) CD8+ T cells from HNSCC, melanoma, and CRC are specific for tumor antigens (8–11). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.